Home » Topics » Regulatory » Patents

Patents
RSS

Shionogi describes new high affinity nerve growth factor receptor inhibtors

Jan. 24, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

Jan. 24, 2017

Genentech and Roche present novel PI3Kalpha and PI3Kdelta inhibitors

Jan. 23, 2017

Janssen discloses new sulfamoylarylamide derivatives for HBV infection

Jan. 23, 2017

The University of Michigan discovers GRK2, GRK5 inhibitors

Jan. 23, 2017

Bristol-Myers Squibb patents novel indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 23, 2017

Merck & Co. describes novel PDE2A inhibitors

Jan. 23, 2017

Jilin University and Shanghai Pharmaceuticals Holding identify new JAK inhibitors

Jan. 20, 2017

Roche divulges novel DDR1 inhibitors

Jan. 20, 2017

Lilly identifies novel MetAP2 and DPP IV inhibitors

Jan. 20, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...